Paul Cohen is a consultant at the Western Australian Gynaecological Cancer Service, King Edward Memorial Hospital in Perth, Clinical Professor in the Division of Obstetrics and Gynaecology, Medical School, University of Western Australia, and Adjunct Professor at the Institute for Health Research, University of Notre Dame Australia. Paul’s research interests include patient-reported outcomes and the supportive care of patients affected by gynaecological malignancies, gynaecological cancer genetics, the epidemiology of gynaecological malignancies, and biomarkers to predict histological tumour regression in women with high-grade serous tubo-ovarian cancer following neoadjuvant chemotherapy.

Paul is the current chair of the International Gynecological Cancer Society (IGCS) Education Committee, and the Australia and New Zealand Gynaecological Oncology Group (ANZGOG) Research Advisory Committee, past program chair of the ANZGOG Annual Scientific Meeting, and a Board Director of ANZGOG and the IGCS. Paul is a member of the eviQ Cancer Genetics Reference Committee, Australian Clinical Trial Alliance Impact and Implementation Committee, and a member of the Editorial Board of the International Journal of Gynecological Cancer.